Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 30

Sort by

Sort Order Select

Journal Articles

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Ayalew Tefferi, MD, Emnet A Wassie, MD, Kebede Begna, MD, Christy Finke, BS, Alem A Belachew, Naseema Gangat, MD, Terra L Lasho, PhD, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Rhett Ketterling, MD

Blood (2014) 124 (21): 631.

https://doi.org/10.1182/blood.V124.21.631.631

Published: 2014

Journal Articles

Imetelstat, a Telomerase Inhibitor, Therapy for Myelofibrosis: A Pilot Study

Ayalew Tefferi, MD, Betsy R. LaPlant, MS, Kebede Begna, MD, Mrinal M. Patnaik, MBBS, Terra L Lasho, PhD, Darci Zblewski, CNP, Christy Finke, BS, Lauren Schimek, Adam Pettinger, Curtis A. Hanson, MD, Naseema Gangat, MD, Animesh Pardanani, MBBS, PhD

Blood (2014) 124 (21): 634.

https://doi.org/10.1182/blood.V124.21.634.634

Published: 2014

Journal Articles

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

Emnet A Wassie, MD, Christy Finke, BS, Naseema Gangat, MD, Terra L Lasho, PhD, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Ketterling Rhett, Ayalew Tefferi, MD

Blood (2014) 124 (21): 403.

https://doi.org/10.1182/blood.V124.21.403.403

Published: 2014

Journal Articles

Comparison of Acute Panmyelosis with Myelofibrosis and Acute Megakaryoblastic Leukemia: A Mayo Clinic Study

Naseema Gangat, MD, Mrinal M. Patnaik, MBBS, Ben Zhang, MD

Blood (2014) 124 (21): 959.

https://doi.org/10.1182/blood.V124.21.959.959

Published: 2014

Journal Articles

Hematopoietic Stem Cell Transplantation As a Successful Salvage Strategy for Relapsed Acute Promyelocytic Leukemia (APL): A Mayo Clinic Series

Gita Thanarajasingam, MD, James M. Foran, MD, Vivek Roy, MD, Lisa Sproat, MD MSW, William J. Hogan, MBChB, Mark R. Litzow, MD, Aref Al-Kali, MD, Naseema Gangat, MD, Mrinal M. Patnaik, MBBS

Blood (2014) 124 (21): 3995.

https://doi.org/10.1182/blood.V124.21.3995.3995

Published: 2014

Journal Articles

Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary Myelofibrosis

Ayalew Tefferi, MD, Paola Guglielmelli, PhDMD, Christy Finke, BS, Terra L Lasho, PhD, Naseema Gangat, MD, Rhett Ketterling, MD, Curtis A. Hanson, MD, Animesh Pardanani, MBBS, PhD, Alessandro M. Vannucchi, MD

Blood (2014) 124 (21): 406.

https://doi.org/10.1182/blood.V124.21.406.406

Published: 2014

Journal Articles

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Blood (2014) 124 (21): 405.

https://doi.org/10.1182/blood.V124.21.405.405

Published: 2014

Journal Articles

Temozolomide Induced Bone Marrow Suppression- a Single Institution Outcome Analysis and Review of Literature

Taxiarchis Kourelis, MD, Jan C Buckner, MD, Naseema Gangat, MD, Mrinal M. Patnaik, MBBS

Blood (2014) 124 (21): 1602.

https://doi.org/10.1182/blood.V124.21.1602.1602

Published: 2014

Journal Articles

Familial Myeloid Neoplasms: Clinical Spectrum and Associated Abnormalities

Samith T. Kochuparambil, MBBS, Amie E Jackson, MD, Naseema Gangat, MD, Mark R. Litzow, MD, Shakila Khan, MD, Vilmarie Rodriguez, MD, William J. Hogan, MD, David Dingli, M.D., Ph.D., Mrinal M Patnaik, MBBS

Blood (2013) 122 (21): 2794.

https://doi.org/10.1182/blood.V122.21.2794.2794

Published: 2013

Journal Articles

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

Blood (2013) 122 (21): 104.

https://doi.org/10.1182/blood.V122.21.104.104

Published: 2013

Journal Articles

Real-World “myelodysplastic Syndrome-unclassifiable” and Its Comparison With “refractory Cytopenia With Multi-Lineage dysplasia” and “refractory anemia”

Kebede Begna, MD, Mrinal M. Patnaik, MBBS, Naseema Gangat, MD, Biruk Mengistu, MD, Curtis A. Hanson, MD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 1574.

https://doi.org/10.1182/blood.V122.21.1574.1574

Published: 2013

Journal Articles

Lack of Prognostic Significance of Monosomal Karyotype and Absolute Lymphocyte Count At Diagnosis in Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

Saad J. Sirop, MD, Aref Al-Kali, MD, Kebede Begna, MD, Naseema Gangat, MD, Louis Letendre, MD, Luis F. Porrata, MD, William J Hogan, MD, Mark R Litzow, MD, Mrinal M. Patnaik, MBBS, MD

Blood (2012) 120 (21): 1476.

https://doi.org/10.1182/blood.V120.21.1476.1476

Published: 2012

Journal Articles

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Shaina A Rozell, MD, Biruk Mengistu, M.D., Naseema Gangat, MD, Curtis A. Hanson, MD, Ryan A Knudson, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 1742.

https://doi.org/10.1182/blood.V120.21.1742.1742

Published: 2012

Journal Articles

Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)

Naseema Gangat, MD, Mrinal M. Patnaik, MBBS, MD, Kebede Begna, MD, Taxiarchis Kourelius, MD, Ryan A Knudson, Rhett P Ketterling, MD, Janice M Hodnefield, MS, MT(ASCP), Curtis A Hanson, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 423.

https://doi.org/10.1182/blood.V120.21.423.423

Published: 2012

Journal Articles

Prognostic Interactions Between SRSF2 , ASXL1 , and IDH Mutations in Primary Myelofibrosis and Determination of Added Value to Cytogenetic Risk Stratification and DIPSS-Plus

Terra L. Lasho, MT, (ASCP), Naseema Gangat, MD, Christy Finke, BS, Rebecca R. Laborde, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Ryan A. Knudson, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 430.

https://doi.org/10.1182/blood.V120.21.430.430

Published: 2012

Journal Articles

Decreased Levels of Total or HDL Cholesterol in Primary Myelofibrosis Are Associated with Shortened Survival: DIPSS-Plus Independent Prognostic Value.

Nanna Sulai, Biruk Mengistu, M.D., Naseema Gangat, MD, Curtis A. Hanson, MD, Rhett P Ketterling, MD, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2012) 120 (21): 2851.

https://doi.org/10.1182/blood.V120.21.2851.2851

Published: 2012

Journal Articles

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Ayalew Tefferi, MD, Animesh Pardanani, MBBS, PhD, Naseema Gangat, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Alessandro M. Vannucchi, MD, Enrica Morra, Mario Cazzola, Arturo Pereira, MD. PhD, Francisco Cervantes, MD, Francesco Passamonti, MD

Blood (2011) 118 (21): 3833.

https://doi.org/10.1182/blood.V118.21.3833.3833

Published: 2011

Journal Articles

Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients,

Blood (2011) 118 (21): 3846.

https://doi.org/10.1182/blood.V118.21.3846.3846

Published: 2011

Journal Articles

Sensitivity and Specificity of Laboratory Parameters to Detect Early/Prefibrotic Myelofibrosis in 857 Patients with Essential Thrombocythemia. A Diagnostic Algorithm

Alessandra Carobbio, MSc, Guido Finazzi, MD, Juergen Thiele, Hans-Michael Kvasnicka, Francesco Passamonti, MD, Elisa Rumi, Marco Ruggeri, MD, Francesco Rodeghiero, MD, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, MD, Elisabetta Antonioli, Heinz Gisslinger, MD, Veronika Buxhofer-Ausch, Naseema Gangat, MD, Alessandro Rambaldi, Ayalew Tefferi, MD, Tiziano Barbui, MD

Blood (2011) 118 (21): 5148.

https://doi.org/10.1182/blood.V118.21.5148.5148

Published: 2011

Journal Articles

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Ayalew Tefferi, MD, Naseema Gangat, MD, Rakhee Vaidya, MD, Kebede Begna, MD, Curtis A. Hanson, MD, Daniel L. Van Dyke, Ph.D., Domenica Caramazza, Animesh Pardanani, MBBS, PhD

Blood (2011) 118 (21): 2806.

https://doi.org/10.1182/blood.V118.21.2806.2806

Published: 2011

NARROW

Revised Cytogenetic Risk Stratification in Primary Myelofibrosis: A Mayo Clinic Study of 903 Patients

Imetelstat, a Telomerase Inhibitor, Therapy for Myelofibrosis: A Pilot Study

A Compendium of Cytogenetic Abnormalities in Myelofibrosis: Molecular and Phenotypic Correlates in 826 Patients

Comparison of Acute Panmyelosis with Myelofibrosis and Acute Megakaryoblastic Leukemia: A Mayo Clinic Study

Hematopoietic Stem Cell Transplantation As a Successful Salvage Strategy for Relapsed Acute Promyelocytic Leukemia (APL): A Mayo Clinic Series

Integration of Mutations and Karyotype Towards a Genetics-Based Prognostic Scoring System (GPSS) for Primary Myelofibrosis

Mutation-Enhanced International Prognostic Scoring System (MIPSS) for Primary Myelofibrosis: An AGIMM & IWG-MRT Project

Temozolomide Induced Bone Marrow Suppression- a Single Institution Outcome Analysis and Review of Literature

Familial Myeloid Neoplasms: Clinical Spectrum and Associated Abnormalities

Effect of the Number of Prognostically Relevant Mutated Genes on Survival and Leukemia Progression in Primary Myelofibrosis

Real-World “myelodysplastic Syndrome-unclassifiable” and Its Comparison With “refractory Cytopenia With Multi-Lineage dysplasia” and “refractory anemia”

Lack of Prognostic Significance of Monosomal Karyotype and Absolute Lymphocyte Count At Diagnosis in Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia

The Effect of Number of Metaphases Studied and Abnormal Metaphase Percentage On Cytogenetic Risk Stratification in Primary Myelofibrosis

Evaluation of IPSS-Revised (IPSS-R) Cytogenetic Risk Stratification and Prognostic Impact of Monosomal Karyotype in 1,014 Patients with Myelodysplastic Syndromes (MDS)

Prognostic Interactions Between SRSF2 , ASXL1 , and IDH Mutations in Primary Myelofibrosis and Determination of Added Value to Cytogenetic Risk Stratification and DIPSS-Plus

Decreased Levels of Total or HDL Cholesterol in Primary Myelofibrosis Are Associated with Shortened Survival: DIPSS-Plus Independent Prognostic Value.

Leukemia Risk Models in Primary Myelofibrosis: An International Working Group Study,

Risk Factors for Thrombosis in WHO-Defined Early/Prefibrotic Myelofibrosis: An International Study of 264 Patients,

Sensitivity and Specificity of Laboratory Parameters to Detect Early/Prefibrotic Myelofibrosis in 857 Patients with Essential Thrombocythemia. A Diagnostic Algorithm

Predictors of Greater Than 80% Two-Year Mortality in Primary Myelofibrosis: A Mayo Clinic Study of 884 Karyotypically-Annotated Cases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only